Last update 10 Jun 2025
Capella Therapeutics, Inc.

Capella Therapeutics, Inc.

Startups
| Private Company|2014|California, United States|
10-50
|
www.capellatherapeutics.com

Overview

Tags

Neoplasms
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
EGFR L858R x EGFR T790M1
EGFR exon 20(EGFR exon 20 Mutation)1

Related

2
Drugs associated with Capella Therapeutics, Inc.
LL-191
Target
EGFR exon 20
Mechanism
EGFR exon 20 inhibitors
Active Org.
Capella Therapeutics, Inc.Capella Therapeutics, Inc.
Originator Org.
Capella Therapeutics, Inc.Capella Therapeutics, Inc.
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
LL-001
Target
EGFR L858R x EGFR T790M
Mechanism
EGFR T790M inhibitors [+1]
Active Org.
Capella Therapeutics, Inc.Capella Therapeutics, Inc.
 [+1]
Originator Org.
University of California San DiegoUniversity of California San Diego [+1]
Active Indication
Non-small cell carcinoma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Capella Therapeutics, Inc.
Login to view more data
0 Patents (Medical) associated with Capella Therapeutics, Inc.
Login to view more data
100 Deals associated with Capella Therapeutics, Inc.
Login to view more data
100 Translational Medicine associated with Capella Therapeutics, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
3
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free